PMID: 39793696

Female Syrian hamster analyses of bremelanotide, a US FDA approved drug for the treatment of female hypoactive sexual desire disorder.

Borland Johnathan M, Kohut-Jackson Abigail L, Peyla Anna C, Hall Megan Al, Mermelstein Paul G, Meisel Robert L

Neuropharmacology · 2025

Vol. 267, pp. 110299

This entry links to third-party literature. For research use only.